To directly test the importance of these molecules in cellsubstratum adhesion, these proteins were purified by a combination of ion exchange, lectin affinity, and immunoaffinity chromatography and used to block the biological activity of the adhesion-disrupting polyclonal antibody. Immunofluorescence experiments further supported the role of these glycoproteins in adhesion. The GPIIb/IIIa-like receptor localized to wellformed adhesion plaques on EC plated on fibrinogen, but not on fibronectin, laminin, or type IV collagen. Receptors containing the $, subunit were visualized as discontinuous fibrils which colocalized with fibronectin fibrils and actin stress fibers.
Introduction
Endothelial cells (EC)' are attached to blood vessel walls in a polarized fashion to form the luminal surface of the vascular system providing a nonthrombogenic permeability barrier bePortions of this paper were presented at the American Federation of Clinical Research annual meeting in Washington, D.C., 29 April-2 May, and appeared in abstract form (1988. Clin. Res. 36:502A).
1. Abbreviations used in this paper: EC, endothelial cell(s); ECM, extracellular matrix; TNC, Tris/NP-40/calcium buffer, VLA, very late antigen; WGA, wheat germ agglutinin.
tween the blood and extravascular tissues (1) . In this capacity, they are subjected to large shear forces and changes in hydrostatic pressures. Since disruption of EC adhesion can lead to tissue edema, as well as the attachment of platelets and leukocytes to the normally inaccessible subendothelial matrix (2) , an understanding of the factors that control normal EC adhesion to the substratum has great importance in a wide variety ofdisease states such as atherosclerosis or the adult respiratory distress syndrome.
Endothelial cells can attach and spread on a number of substrates in vitro including fibronectin, gelatin, collagens, fibrinogen, laminin, von Willebrand's factor, and vitronectin, as well as to the basement membrane produced by other cells in culture (3) (4) (5) (6) (7) . The actual mechanism by which EC attach to these extracellular matrix molecules is not known. It is likely, however, that this process is mediated by members of the recently defined family of cell surface glycoproteins, designated "integrins," (8) which serve as cell adhesion receptors. These receptors, which bridge the cytoskeletal elements of a cell to the extracellular matrix (ECM), are glycoproteins consisting of an a subunit (120-200 kD) noncovalently bound to a highly disulfide cross-linked (i subunit (80-120 kD) (8) (9) (10) . The integrin family is made up of several subfamilies ofreceptors, each subfamily being defined by a common i subunit (8, 9) . The specificity for individual ECM molecules arises from the association of the common # subunit with different a subunits within each family. Members of the Integrin family, grouped according to homology in their (B subunits include: (a) the avian integrin receptors (1 1) , the mammalian fibronectin receptor (12, 13), a laminin receptor (14) , at least two types of collagen receptors (15) , and the very late antigens (VLA) (16) ; (b) the Leu-CAMS, including leukocyte membrane proteins LFA-1, Mac-l, and p150/90 (17) ; and (c) the cytoadhesins (18) which include platelet glycoproteins GPIIb/IIIa (19) and the mammalian vitronectin receptor (20) .
To date, the repertoire of cell-substratum adhesion receptors present on the EC has not been defined with the exception of a receptor related to the platelet IIb/IIIa glycoprotein complex (21) (22) (23) (24) (25) (26) (27) (28) (29) . Recent work has shown that antibodies directed against the platelet IIb/IIIa complex can affect the adhesion of umbilical vein endothelial cells to certain substrates (22) (23) (24) .
The purpose of this report was to further identify and characterize proteins on the surface of a variety of human EC which might function as extracellular matrix receptors.
Methods
Cell culture. Human adult large vessel and umbilical vein EC were isolated and cultured as previously described (30) (31) (32) . Iliac artery or vein segments were obtained from renal transplant donors. Adult fat techniques (33) . An endothelial cell identity was confirmed by morphology, immunofluorescent staining for factor VIII-related antigen, and detection of angiotensin-converting enzyme activity (30, 34 ). All cultures were tested periodically and found to be free of mycoplasma infection (34) . Some umbilical vein cultures were not passaged but used as primary cultures.
Antibodies. A complete listing of antibodies used in these studies, including their documented specificities and their sources, is found in Table I .
The following polyclonal antisera were used: (a) hamster anti-GP140, raised in goats against the 140-kD cell adhesion glycoproteins isolated from BHK21/C13 cells (35) ; this antibody has been shown to cause reversible alterations in cell adhesion and spreading in a number of mammalian cell types (35) (36) (37) ; (b) rat anti-GP140, an antiserum raised in a rabbit against the 140-kD adhesion receptor complex present in the rat L6A cell line prepared as previously described ( 11); (c) a polyclonal anti-hamster fibronectin receptor antibody raised in goats (kindly provided by Dr. R. L. Juliano) (13); and (d) a polyclonal rabbit antibody raised against the chicken integrin molecule (38) .
A monoclonal antibody raised against platelet glycoprotein Ila (#3 subunit) was provided by Dr. Joel Bennett and Dr. James Hoxie of the University of Pennsylvania (39) .
The following monoclonal antibodies were kindly provided by Drs. Elizabeth Wayner and William Carter ( 15): P1H5, directed against the a subunit of a collagen-specific adhesion receptor (anti-class II ECM receptor); PlB5, directed against the a subunit ofa multifunctional cell adhesion receptor with activity against cells plated on fibronectin, laminin, and collagen (anti-class I ECM receptor); and PI D6, directed against the a subunit of the mammalian fibronectin receptor (40) . It should be noted that the ECM class II receptor corresponds to VLA-2 and the ECM class I receptor corresponds to VLA-3 (41).
Dr. Martin Hemler provided the following monoclonal antibodies (16, 42) : A-lA5, directed against the jB subunit of the VLA antigens; TS2/7, which recognizes the VLA-1 complex; and B-5H10, directed against the VLA-4 complex.
Use of antibodies to inhibit EC adhesion. Tissue culture plates (96-well) were coated with purified matrix substances. Laminin (provided by Dr. Hynda Kleinman, National Institutes of Health, Bethesda, MD) was dissolved in sterile water (final concentration 10 zg/ml). Type IV/V collagen, prepared from human placentas (the gift of Dr. Stuart Williams) was prepared by diluting a l-mg/ml stock solution (in 1 mM acetic acid) into a 0.05 M sodium carbonate buffer (final concentration 10 Ag/ml). Each of these solutions was added to the tissue culture plate and allowed to incubate at 37°C overnight. Human fibronectin (New York Blood Center) (final concentration 10 ,ug/ml) and gelatin (1%) dissolved in PBS were added to the plates and incubated for 2 h at 37°C. 30 min before each experiment, each well was aspirated, washed twice with PBS, and then flooded with medium M199 supplemented with 2.5 mg/ml of BSA to block nonspecific binding. Immediately before adding the cells, the media in each well was replaced with 100 jd of complete tissue culture media containing various dilutions of hamster or rat anti-GP140. EC were trypsinized and 5 X 103 cells, suspended in 100 Ml of complete media, were added to each well. After 18 h, wells were scored for the presence of rounded cells.
The initial adhesion of EC to various matrix proteins in the presence of antibodies was also studied. To prevent the synthesis of EC matrix proteins during the initial adhesion period, confluent flasks of endothelial cells were refed with complete tissue culture media containing cycloheximide (25 ;g/ml) 1 h before each experiment. This concentration of cycloheximide has been shown to effectively inhibit protein synthesis while maintaining cell viability over the short term Monoclonal against common # chain of VLA antigens (#I (42) Fibronectin subunit, also known as platelet GPIIa)
Monoclonal against the a chain of VLA-l (a,) (16) Unknown
B-5G10
Monoclonal against the a chain of VLA-4 (a4) (43) without the use of reducing agents. Gels were impregnated with En3Hance (New England Nuclear) and exposed to XR-5 x-ray film (Eastman Kodak Co., Rochester, NY) at -70°C.
Blocking assay. This assay was based on the assumption that any material in the NP-40 extract (or other fractions) capable of blocking the ability of the anti-GP140 to prevent EC adhesion and spreading must contain components related to the maintenance of adhesion (35, 44) .
The concentration of hamster anti-GP140 required to inhibit the adhesion and spreading of endothelial cells plated on gelatin was determined by plating -1.5 X I04 cells/cm2 into tissue culture medium containing various dilutions of the antibody. After 18 h, wells were scored for the presence ofrounded cells. Although we found that activity was detectable at dilutions of up to 1:100, for purposes of a screening assay, we routinely used the antibody at 1:50 dilution, a concentration that induced rounding in 90-lOOO% of the cells.
NP-40 extracts to be tested for blocking activity were processed as previously described (35) . Samples were added to individual wells of a 96-well microtiter plate (that had been precoated with gelatin, fibronectin, fibrinogen, type IV collagen, or laminin) followed by 100 Purification ofNP-40 extracts. 1-3 ml of NP-40 extract (which had been dialyzed for 18 h against TNC buffer to remove residual salt) was applied to an Affigel 102 (35) column and fractions were collected at about 1 ml every 5 min. The column was washed with TNC buffer and then eluted with buffer containing 0.01, 0.05, 0.1, 0.5, and 1.0 M NaCl, respectively. Each fraction (1.0 ml) was monitored for radioactivity and bioactivity in the blocking assay. Active fractions from the Affigel 102 column were pooled and applied to a wheat germ agglutinin (WGA) column followed by extensive washing with TNC/0.15 M NaCI. Bound material was eluted using 0.2 M N-acetyl-D-glucosamine in TNC buffer in l-ml fractions which were monitored for radioactivity and bioactivity. Active fractions from the WGA column eluates were pooled and applied to a column containing 1 ml of antiplatelet glycoprotein lila antibody coupled to Sepharose which had been preequilibrated with TNC buffer containing 0.15 M NaCI. After extensive washing with buffer, bound material was eluted with 50 mM diethylamine in 0.01 M Tris acetate, 0.5 mM Ca2+, 0.05% NP-40 that had been adjusted to pH 1.5. Each l-ml fraction was neutralized, dialyzed against TNC/0. 15 M NaCI overnight at 40C, and tested for bioactivity.
Immunofluorescence. EC were plated at subconfluent densities on glass coverslips coated with various matrix substance as described above. Two protocols were used for plating the EC. In the first, the cells were dispersed with trypsin/EDTA, the trypsin was neutralized with soy trypsin inhibitor, and the cells were resuspended and plated in serum-free medium M199 with 2.5 mg/ml BSA and fixed 3 h later. In some experiments, 25 gg/ml of cyclohexamide was added 1 h before typsinization and was present throughout the incubation period. In the second, the trypsin/EDTA was neutralized, with medium-containing serum, and the cells were plated in complete medium M199 and then processed for immunofluorescent staining after 18 h. Staining was performed using the method of Damsky et al. (38) . Briefly, cells were fixed with 3% paraformaldehyde and permeabilized with 1% NP-40 for 1 min. Antibody or preimmune serum was added for 1 h and after rinsing, the cells were stained with a 1:200 dilution of fluorescein-labeled anti-mouse or rhodamine anti-goat antibodies for 1 h. Cells were viewed on a phase-epifluorescent microscope (Carl Zeiss, Inc., Thornwood, NY) using a 63X planapochromat oil-immersion lens numerical aperture 1.4 and photographed using Tri-X film.
Results
Effect of anti-adhesion receptor antibodies on EC adhesion.
To determine the activity of anti-GP140 on initial adhesive events, cells were plated onto different substrates in the presence or absence of anti-hamster GP140. As shown in Fig. 1 , initial adherence (3 h after plating) of EC to laminin, type IV collagen, and fibronectin was affected only slightly by the antibody, whereas there were marked inhibitory effects on cells plated on fibrinogen or gelatin. After 18 h of exposure, however, there was complete detachment of cells plated on lamifin, collagen, and fibronectin. A typical example is shown in Fig. 2 . A similar effect was noted in experiments using the anti-rat GP 140 antiserum. Preimmune serum had no effects on cell adhesion. The actions of the antisera were blocked by nonionic detergent extracts of endothelial cells (Fig. 2) . When the antisera were removed from the media, the remaining cells reverted to their normal morphology, demonstrating that the effect was not due to irreversible cytotoxicity.
Identification of EC surface proteins reactive with adhesion-disrupting antisera. Nonionic detergent extracts of [35S]-methionine-labeled EC were immunoprecipitated with the antibodies that perturbed cell-substrate adhesion (anti-hamster and rat GP140). These antisera precipitated polypeptides migrating in the molecular mass range of 150, 125, 110, and 95 kD from human adult large vessel endothelial cells (Fig. 3,   lanes a, b, and e) , adult human fat capillary cells (Fig. 4, lower panel, lane a) primary umbilical vein endothelial cells (Fig. 4, 1994 Albelda et al. Monoclonal antibodies known to be specific for subunits ofthe integrin family of receptors were used to further identify these glycoproteins (Table I, Figs. 3 and 4) . A monoclonal antibody reactive with GPIIIa (anti-,B3) from human platelets (39) immunoprecipitated two glycoproteins corresponding to the 150-and 95-kD polypeptides precipitated by the anti-GP 140 antibodies (Fig. 3, lane d; Fig. 4, lane b) . These proteins almost certainly represent the platelet glycoprotein IIb/IIIalike complex from endothelial cells previously described by others (21, (26) (27) (28) (29) . A monoclonal antibody directed against the common *S subunit (A-lA5) immunoprecipitated two bands that had molecular masses of 150 and 125 kD (Fig. 3 , lane i). This immunoprecipitate also contained a 1 0-kD protein which may represent a precursor of the 125-kD subunit dilution of anti-GPl 40 were added to the substratecoated wells followed by the addition of 4 X I04 trypsinized EC suspended in 250 ,ul of complete media. After 3 h, the wells were washed twice with PBS and the cells counted electronically. Initial adhesion of EC to laminih, type IV collagen, or fibronectin was relatively unaffected. In contrast, anti-0P140 had marked effects on the initial adhesion of EC to fibrinogen and gelatin.
reported by us and others (45, 46) or a yet unidentified subunit. The monoclonal antibodies directed against the a subunit ofclass I (PIB5) and class II (PlH5) ECM receptors, as well as the fibronectin receptor (PlD6)j also precipitated bands at 150 and 125 kD (Fig. 3, lanesf-h; Fig. 4, lanes c-e) . Monoclonal antibodies against VLA-l and VLA-4 did not immunoprecipitate proteins from the endothelial cells (Fig. 3, lanes j,   k) . The polyclonal antibody against the hamster fibronectin receptor also precipitated two proteins, but the molecular masses were 125 and 110 kD (Fig. 3, lane c) . A weak band was also seen at 150 kD. The lower two bands correspond exactly to the middle bands immunoprecipitated by both anti-GP 140 antibodies. The polyclonal antibody against the avian integrin receptor immunoprecipitated proteins of the same molecular mass as the anti-OP 140 antibodies (data not shown).
The identity of the lower molecular mass protein immu- performed using the f3I-specific monoclonal antibody, A-lA5 (Fig. 6 ). Extracts were immunoprecipitated three times with A-l A5 (Fig. 6, lanes a-c) to remove proteins reactive with this antibody. When the precleared material was immunoprecipitated with rat anti-GP 140 (Fig. 6 , lane e) and compared with the material immunoprecipitated from "uncleared" extract (Fig. 6, lane d) , the 125-kD band was absent, as was most of the material migrating in the 1 50-kD region of the gel, leaving the bands at 95 and 110 kD, and a faint band at 150 kD. These results further show that the 125-kD band represents the A subunit common to the fibronectin receptor and the VLA family of receptors. Purification of an EC adhesion receptor. To further confirm that these proteins are important in EC-ECM adherence, we took advantage of the fact that the inhibition of adhesion and spreading of EC on gelatin mediated by anti-GP 140 could be blocked by the addition of a nonionic detergent extract of EC (Fig. 2) . We used this inhibition as a bioassay to purify EC membrane components important in cell adhesion. Table II summarizes the results of three purification procedures performed with a mixture of nonionic detergent extracts from unlabeled and [35S]methionine-labeled EC. The material that eluted from the Affigel column with 0.05 M NaCl contained all the blocking activity. When this active fraction was passed over the WGA-lectin column, all the activity was found in the material adherent to the column. SDS-PAGE followed by either autoradiography or silver staining of the active material eluted from the Affigel (Fig. 7 a) and the WGA columns (Fig. 7 b) revealed that this two-step purification resulted in a preparation enriched in polypeptides migrating in the 150-, 125-110-, and 95-kD region of the gel. Immunoblotting experiments using this purified material showed cross reactivity with the antiplatelet GPIIIa monoclonal antibody (95-kD band), polyclonal antibodies to rat anti-GP140 (110-and 125-kD bands) and to avian integrin (110-, 125-, and 150-kD bands). To further purify this complex, the material was passed over an affinity column made from the anti-53 monoclonal antibody. Upon elution with diethylamine, the material that bound to the column revealed only the 150-and 95-kD proteins (Fig. 7 c) . Not surprisingly, the lower molecular mass protein cross reacted with the anti-GPIIIa monoclonal antibody in immunoblots. SDS-PAGE of the material passing through the anti-t3 monoclonal column revealed proteins that migrated in the 150-, 125-, and 1 l0-kD regions of the gel, but no material in the 95-kD region, confirming the results of the immunoadsorption experiments.
The glycoproteins eluted from the WGA column, the purified Ilb/IlIa-like complex, and the material that passed through the anti-IlIa monoclonal antibody column were assayed for their ability to block the effects of anti-GP 140 on a variety of substrates, in addition to gelatin (Table II) . The material eluted from the WGA column and the material that passed through the anti-IIIa monoclonal antibody column neutralized the effect of anti-GP 140 on all substrates. In contrast, the 150/95-kD dimer eluted from the anti-IIIa monoclonal antibody column blocked the effects of anti-GP 140 when EC were plated on fibrinogen and gelatin but not when plated on fibronectin, collagen, or laminin. This suggests that the 150/95-kD complex plays a major role in EC adhesion to fibrinogen and gelatin, but other receptors are involved in the adhesion to fibronectin, laminin, and collagen. Distribution ofadhesion receptors on EC. The distribution of ECM receptors on EC cells was examined by fluorescence microscopy. To determine which receptors the EC would utilize when presented with defined substrata, the cells were plated in the presence or absence of cyclohexamide (to suppress endogenous fibronectin production), in serum-free medium on wells coated with fibronectin, fibrinogen, and, in some cases, collagen and laminin. After 3 h, cells were fixed and stained with monoclonal antibodies specific for either (3 or f3 integrin subunits.
When cells were plated onto coverslips coated with fibronectin or fibrinogen and subsequently stained with an antibody specific for the fB subunit of the fibronectin receptor, a pattern such as that shown in Fig. 8 , A and C, was obtained. Immunofluorescence was seen in thin filamentous arrangements along the ventral cell surface. This pattern closely followed the actin-containing stress fibers found in these cells (data not shown). This pattern also resembled, in both shape and distribution, that seen when these same cells were stained with anti-fibronectin antibodies (Fig. 9 B) . In contrast, when EC plated on fibronectin were stained with antibodies specific for the a3i subunit of the fibrinogen receptor, there were no adhesive structures noted (Fig. 9 B) . However, if cells were plated on fibrinogen and stained with anti-,83 antibodies, welldefined focal contactlike structures were noted at the cells periphery (Fig. 8 D) . These receptors were different in both distribution and shape from those noted when cells were stained with anti-#, antibodies (compare Fig. 8, A and C, with D) .
These data showed that the /33-containing receptors were only organized by the cell in response to exposure to the appropriate ECM. The codistribution of the AI-containing receptors and cellular fibronectin suggested that the appearance of adhesive structures on cells plated on fibrinogen was due to the presence of fibronectin produced by these cells. To test this possibility, cells were plated on fibrinogen in the presence and absence of cyclohexamide to inhibit endogenous protein synthesis. In the absence of cycloheximide, these cells produced fibronectin as detected by anti-fibronectin antibodies (Fig. 9 B). They also organized their #,B-containing subunits into the thin, fibrous adhesive structures (Fig. 9 A) . In the presence of cycloheximide, however, there were few, if any, adhesive structures formed which contained /3I subunits (Fig. 9 C) and similarly, little fibronectin was detected (Fig. 9 D) . Cells Since cells are not normally presented with one clearly defined choice of substrate, and since serum is normally present during cell growth, we repeated the above experiments in the presence of serum after 24 h in culture. The morphology of the adhesive structures, as well as their distribution, was exactly like that seen in Fig. 8 on all substrates. The (31-containing receptors localized exclusively to fibrillar structures and the fibrinogen receptors were found in broad, brush strokelike structures localized at the cell periphery or at the leading lamella.
Discussion
We have used a combination of polyclonal and monoclonal antibodies to determine the repetoire of cell-substratum adhesion receptors expressed by human EC. The polyclonal anti-GPI40 antibodies, which disrupt EC adhesion to fibronectin, fibrinogen, collagen, laminin, and gelatin, immunoprecipitated a set of proteins ranging in molecular mass from 150 to 95 kD. Differential immunoprecipitation with a series of monoclonal antibodies reactive with specific subunits of members ofthe integrin superfamily (Table I) Fig. 4 ). The significance of this finding remains to be determined. It appears unlikely that the differences in EC cell morphology or behavior on various substrates (47, 48) (Fig. 8) . The distribution is characteristic of focal contacts (38) . The receptors stained by the anti-#, monoclonal antibody were more numerous, were found along the entire length of stress fibers, and were finer in morphology, varying from thin brush strokelike structures near the stress fiber termini to thin filamentlike structures found along the length of stress fibers (Fig. 8) . This distribution is similar to that described by others (49) (50) (51) (Fig. 9 A) , we believe that this pattern was due to localization of receptors over endogenously produced fibronectin fibrils (Fig. 9 B) . By exposing the cells to cyclohexamide, which prevented the formation of fibronectin fibrils (Fig. 9 D) , we were able to eliminate most of the fibrillar staining with the anti-d, antibody (Fig. 9 C) .
These results emphasize the importance of matrix proteins produced by the cells in organizing their own adhesion receptors.
As EC adhesion is further dissected, it must be kept in mind that this is a complex event involving several different receptors, each of which may predominate at different times. Data are accumulating which indicate that there is more than one binding site on the fibronectin molecule (53) , and that cooperative interaction of receptors at other binding sites on the molecule may be important for cell attachment, spreading, and locomotion (54) . The finding that both anti-GPI40's were ineffective in blocking initial adhesion of endothelial cells to fibronectin or collagen, but could effectively detach cells from the various substrates after 18 h, supports the idea that the receptor responsible for initial attachment to fibronectin or collagen may be different from the receptor responsible for the spreading and the maintenance of adhesion to these strates. Alternatively, the antibody may not block the binding or clustering of receptors in the presence of ECM molecules, but may interfere with the organization of receptors into adhesion structures required for cell spreading. Neural cells also show this difference in sensitivity of initial adhesive event and cellspreading to disrupting agents (54).
In the blood vessel, some or all of these receptors may act in concert to maintain the integrity of the vascular lining against stress, while during the processes of cell migration or vascular development, one or the other ofthese receptors may be of predominant importance. As we begin to look more closely at the process of EC adhesion, it will be important to determine this hierarchy of receptor function, the molecular organization of these receptors, as well as whether they are involved in the generation ofsignals required for the control of cell behavior or division.
